STARD13 and cancer: Rho-GTPase-activating proteins (ARHGAP) serve as negative regulators of Rho-GTPases, and alteration in the genes and transcriptomes of the ARHGAP family can exert a carcinogenesis effect through Rho-like GTPase dysregulation in several cancer types.